U.S. Markets close in 1 hr 44 mins
  • S&P 500

    4,535.92
    +16.29 (+0.36%)
     
  • Dow 30

    35,627.78
    +170.47 (+0.48%)
     
  • Nasdaq

    15,119.79
    -9.30 (-0.06%)
     
  • Russell 2000

    2,288.26
    +12.35 (+0.54%)
     
  • Gold

    1,786.30
    +15.80 (+0.89%)
     
  • EUR/USD

    1.1659
    +0.0022 (+0.1865%)
     
  • 10-Yr Bond

    1.6410
    +0.0060 (+0.37%)
     
  • Vix

    15.55
    -0.15 (-0.96%)
     
  • GBP/USD

    1.3831
    +0.0038 (+0.2739%)
     
  • USD/JPY

    114.2210
    -0.1390 (-0.1215%)
     
  • BTC-USD

    66,500.54
    +3,230.38 (+5.11%)
     
  • CMC Crypto 200

    1,547.93
    +67.13 (+4.53%)
     
  • FTSE 100

    7,223.10
    +5.57 (+0.08%)
     
  • Nikkei 225

    29,255.55
    +40.03 (+0.14%)
     

9 Meters Biopharma, Inc. to Present at the Jefferies Virtual Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

RALEIGH, NC / ACCESSWIRE / June 1, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that John Temperato, CEO of 9 Meters Biopharma will present at the Jefferies Virtual Healthcare Conference being held June 1- 4, 2021 and invites investors to participate via webcast and in one-on-one meetings. The presentation will be followed by a virtual Q&A session.

Jefferies Virtual Healthcare Conference

Date: June 4th, 2021
Time: 12:30 to 12:55 p.m. (ET)
Presenter: John Temperato, CEO of 9 Meters Biopharma
Webcast: https://wsw.com/webcast/jeff174/nmtr/1878903

* a replay will be available following the presentation for 30 days

Please contact your Jefferies representative to schedule virtual one-on-one meetings with the
9 Meters Biopharma management team during the conference.

About Jefferies Virtual Healthcare Conference

The annual June conference will be held virtually with video presentations, keynotes, panels and 1x1/small group meetings via Zoom.

This virtual gathering of over 400 public & private healthcare companies and 3,000 leading executives, institutional investors, private equity investors & VCs will address near- and long-term investment opportunities and discuss the current trends driving healthcare in the U.S. and internationally.

For further information, please visit: www.Jefferies.com

About 9 Meters Biopharma
9 Meters Biopharma, Inc. ("the Company") is a rare and unmet needs-focused gastroenterology company. The Company is advancing vurolenatide, a proprietary long-acting GLP-1 agonist, into a Phase 2 trial for short bowel syndrome (SBS), a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for symptom improvement in non-responsive celiac disease.

For more information, please visit www.9meters.com or follow 9 Meters on Twitter and LinkedIn.

Corporate Contacts:

Edward J. Sitar
Chief Financial Officer
9 Meters Biopharma, Inc.
investor-relations@9meters.com
www.9meters.com

Media Contact:

Veronica Eames
LifeSci Communications, LLC
veames@lifescicomms.com
203-942-4626

Investor Contact:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
cdavis@lifesciadvisors.com
212-915-2577

SOURCE: 9 Meters Biopharma



View source version on accesswire.com:
https://www.accesswire.com/649585/9-Meters-Biopharma-Inc-to-Present-at-the-Jefferies-Virtual-Healthcare-Conference